Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.0900
0.00 (0.00%)
Jun 30, 2026, 9:32 AM EST
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of CAD 25.57 million as of July 1, 2026. Its market cap has increased by 430.89% in one year.
Market Cap
25.57M
Enterprise Value
22.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has increased from 17.41M to 25.57M, an increase of 46.84%. That is a compound annual growth rate of 5.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 25.57M | 110.85% |
| Dec 30, 2025 | 12.13M | 164.72% |
| Dec 31, 2024 | 4.58M | 131.55% |
| Dec 29, 2023 | 1.98M | -35.51% |
| Dec 30, 2022 | 3.07M | -54.48% |
| Dec 31, 2021 | 6.74M | -73.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedMira | 49.12M |
| Microbix Biosystems | 40.64M |
| Defence Therapeutics | 37.89M |
| BriaCell Therapeutics | 37.84M |
| Medicenna Therapeutics | 37.38M |
| Quantum BioPharma | 34.30M |
| Resverlogix | 30.95M |
| Sharp Therapeutics | 30.08M |